Anavex regains Nasdaq compliance after filing delinquent 10-Qs for Q2 and Q3 FY2026

ANAVEX LIFE SCIENCES CORP.

Nasdaq confirmed compliance with Listing Rule 5250(c)(1) on September 2, 2026.
Delinquency notice received May 20, 2026; compliance plan submitted July 20, 2026.
Filed 10-Qs for periods ended March 31 and June 30, 2026 on August 28, 2026.
Common stock continues trading on Nasdaq Global Select Market under ticker AVXL.
Company cites advancing all three core CNS indications as ongoing strategy.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.